Cytek Corp - שינוי בהכנסות משנה לשנה ב-12 החודשים האחרונים CTKB

Cytek Biosciences, Inc. (CTKB) operates within a neutral geopolitical environment, maintaining global access to biomedical markets. The rolling 12-month revenue growth trend on the GURU.Markets chart reflects market dynamics, where the value 5.40 captures this metric. Cytek Biosciences, Inc. (CTKB) is integrating AI into cytometry to achieve full laboratory automation, although it faces pressure from budget-friendly tech startups.

The implementation of flow cytometry systems and diagnostic consumables directly determines the cash flow dynamics of Cytek Biosciences (CTKB). By analyzing the year-over-year (YoY) relative revenue growth over a 12-month period, investors track the percentage change in total revenues over a rolling year, which allows them to differentiate organic business expansion from short-term fluctuations and assess the long-term vector of the issuer's fundamental development.